Skip to main content

News

Nice Enters European HVM Market With CE-Certified HySecurity Line

Image
Nice Enters European HVM Market With CE-Certified HySecurity Line

London – September 22, 2026 -- Nice has formalized its entry into the European hostile vehicle mitigation (HVM) market, rolling out CE-certified products from its HySecurity division after previously supplying the region only on a project-by-project basis.

Nice Establishes Structured European Route to Market for HySecurity

HySecurity, acquired by Nice in 2016, brings more than 60 years of expertise in hydraulic gate operators and crash-rated barriers for airports, government facilities and data centres. Nice will now support the division with local commercial and technical teams alongside its existing network of installers and system integrators, moving away from ad hoc project sales.

Dutch Study: E-Scooters, Fatbikes Cut Car Use but Raise Cycling Risk

Image
Dutch Study: E-Scooters, Fatbikes Cut Car Use but Raise Cycling Risk

Breda, Netherlands – September 22, 2026 -- Light electric vehicles (LEVs) such as e-scooters, e-cargo bikes and fatbikes could reduce car dependency in the Netherlands but are simultaneously raising cycling accident risk on the country's shared bike paths, according to research from Breda University of Applied Sciences (BUas).

Dutch cycling network faces new pressure from electric micro-mobility

The Netherlands operates the world's most extensive cycling infrastructure, with 22 million bicycles serving 18 million residents across a 153,000-kilometre network. Bikes account for 28% of all trips nationally, a model increasingly studied and replicated by cities globally. That system is now being tested by a growing volume of LEVs entering the same narrow cycle paths.

Indorama Secures $358M Loan to Double China Fertilizer Output

Image
Indorama Secures $358M Loan to Double China Fertilizer Output

Anyang – September 22, 2026 -- Anyang Indorama Gases Co., Ltd. has signed an RMB 2.4 billion (c. US$358 million) long-term loan facility with five banks to fund a Phase II fertilizer capacity expansion in Anyang City, Henan Province, China.

Financing will double urea capacity to 2 million tonnes annually by 2029

The subsidiary of Singapore-based Indorama Corporation Pte. Ltd. will use the loan to partially fund construction that will double its urea fertilizer capacity, produced from syngas and ammonia, to approximately 2 million tonnes per annum by 2029. The project follows Indorama's acquisition of the Anyang nitrogen fertilizer business earlier in 2026 and marks a brownfield expansion of its Chinese operations.

Essity to Report Q3 2026 Results October 22, CEO Kolsrud to Present

Stockholm – September 22, 2026 -- Essity will publish its interim report for the third quarter of 2026 on October 22 at approximately 07:00 CET, the hygiene and health company confirmed.

CEO and CFO to host live webcast at 09:00 CET

President and CEO Ulrika Kolsrud, together with EVP and CFO Fredrik Rystedt, will present the results via a live webcast and teleconference at 09:00 CET the same day. The session will remain available for on-demand viewing after the live broadcast concludes.

Dial-in access offered across three regions

Investors and analysts seeking to participate in the question-and-answer session can join via dedicated conference lines in the UK, the United States, and Sweden. Essity has instructed participants to call in ahead of the scheduled start and identify themselves as joining the "Essity" call.

Beactica Starts IND-Enabling Studies for Glioblastoma Drug BEA-17

Uppsala, Sweden – September 22, 2026 -- Beactica Therapeutics AB has initiated IND-enabling studies for BEA-17, a first-in-class oral degrader targeting the epigenetic regulators LSD1 and CoREST, moving the glioblastoma therapy toward first-in-human trials.

Beactica targets a cancer with 15-month median survival and no new treatment in over two decades

Glioblastoma remains the most common and aggressive primary brain tumour, with a median overall survival of approximately 15 months. Standard of care has stayed essentially unchanged for more than 20 years, and immunotherapies successful against other cancers have consistently failed against GBM's immunosuppressive tumour microenvironment.

PharmaResearch Launches REJURAN Skin Booster in Hungary

Image
PharmaResearch Launches REJURAN Skin Booster in Hungary

Budapest – September 22, 2026 -- South Korean biopharmaceutical company PharmaResearch officially launched its REJURAN portfolio of polynucleotide (PN)-based skin boosters in Hungary, marking its latest expansion move in Europe's aesthetic medicine market.

Symposium at Budapest museum draws 100 aesthetic medicine professionals

The launch event was held on September 14 at the Museum of Fine Arts, Budapest, marking REJURAN's first collaboration with the institution. Approximately 100 dermatologists, plastic surgeons and other aesthetic medicine specialists attended the symposium, which featured seven speakers from Korea, the Czech Republic, Slovakia and Hungary, including Korean key opinion leaders Dr. Hyun Jun Park and Dr. Kyu Ho Lee.

accesso Launches Agentic AI Tools for Attraction Operators

Image
accesso Launches Agentic AI Tools for Attraction Operators

London – September 22, 2026 -- accesso Technology Group plc (AIM: ACSO) has introduced agentic AI capabilities within its accesso Intelligence platform, allowing visitor attraction operators to convert conversational queries into automated, recurring analytical workflows.

New agentic tools automate monitoring, forecasting and reporting across attraction operations

The update adds three connected capabilities: agentic skills for multi-step performance monitoring and issue detection; agentic automations that schedule or trigger analyses and result distribution; and agentic reporting and forecasting that builds custom, adaptive reports rather than static daily outputs.

Hylenr Completes Phase 1 Validation of Fusion Reactor at Texas A&M

Image
Hylenr Completes Phase 1 Validation of Fusion Reactor at Texas A&M

Hyderabad – September 22, 2026 -- Hyderabad-based deeptech firm Hylenr has completed Phase 1 independent validation testing of its Lattice Confinement Fusion (LCF) reactor at Texas A&M University's Nuclear Engineering Department, detecting elevated helium and argon signals two to three orders of magnitude above background levels.

Texas A&M tests reveal anomalous gas and thermal signatures in BRT-NiUCS-2 reactor

The study, titled 'Validation of Anomalous Heat and Nuclear Signatures in the BRT-NiUCS-2 Reactor: Phase 1 LCF Investigation,' examined the hydrogen-loaded nickel-palladium catalyst reactor using thermal measurement, residual gas analysis, radiation monitoring and post-reaction material characterization. Residual Gas Analysis via an SRS RGA 100 system under high-vacuum conditions found no corresponding rise in nitrogen, ruling out atmospheric leakage as the sole cause of the elevated helium, argon and neon readings.

Temu Signs MoU with ABSL to Support Romanian Business Sector

Image
Temu Signs MoU with ABSL to Support Romanian Business Sector

Bucharest – September 22, 2026 -- Temu has signed a Memorandum of Understanding with the Association of Business Service Leaders in Romania (ABSL), the country's leading body representing shared services, business process outsourcing, IT outsourcing and R&D companies.

Temu joins ABSL as an official E-commerce Partner

Under the agreement, Temu will take part in ABSL's programs and events, engaging directly with the association's network of startups and multinationals operating across shared services, BPO, ITO and R&D in Romania. Temu will also provide expertise and in-kind support to ABSL initiatives.

Creator TV Audience Surges 4.8x as Sabio Unit Joins Sports-Media Panel

Image
Creator TV Audience Surges 4.8x as Sabio Unit Joins Sports-Media Panel

Los Angeles – September 22, 2026 -- Creator TV, the streaming network owned by Sabio Holdings (TSXV: SBIO) (OTCQB: SABOF), reported its audience grew 4.8 times year-to-date through August 2026, hitting a record 305,000 unique viewers that month.

Audience growth accelerates as average monthly viewership climbs 138% year-over-year

Sabio's App Science analytics platform found Creator TV viewers are 2.5 times more likely to stream sports content than average audiences, a data point the company says explains the crossover between creator-economy fans and sports viewership.